These findings, together, suggest that the increased STI1 levels found in AD and PD does not improve or compensate for abnormal chaperone function, or improve extracellular signaling; it may further imbalance the chaperone machinery and is deleterious. This evidence concerns the gene STIP1 and Parkinson disease.